Spinalmax

Wirkstoff: BERBERIS VULGARIS ROOT BARK, BLACK COHOSH, CINCHONA OFFICINALIS BARK, CITRULLUS COLOCYNTHIS FRUIT PULP, RHODODENDRON TOMENTOSUM LEAFY TWIG, RANUNCULUS BULBOSUS, HORSE CHESTNUT, CUPRIC ACETATE, NADIDE, SODIUM DIETHYL OXALACETATE, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, RIBOFLAVIN, THIAMINE HYDROCHLORIDE, ALPHA LIPOIC ACID, AMMONIUM CHLORIDE, SUS SCROFA CARTILAGE, SUS SCROFA INTERVERTEBRAL DISC, PICRIC ACID, SILICON DIOXIDE, SILVER, TRIBASIC CALCIUM PHOSPHATE, SUS SCROFA UMBILICAL CORD, SUS SCROFA ADRENAL GLAND, PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE, SUS SCROFA BONE MARROW, MERCURIC OXIDE, PANTOTHENIC ACID, SULFUR, ENTEROBACTER CLOACAE, SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS, PROTEUS MORGANII, PROTEUS VULGARIS

Flüssigkeit [Übersetzung der Form; Original: LIQUID (openFDA)] · BERBERIS VULGARIS ROOT BARK 4 [hp_X]/mL, BLACK COHOSH 4 [hp_X]/mL, CINCHONA OFFICINALIS BARK 4 [hp_X]/mL, CITRULLUS COLOCYNTHIS FRUIT PULP 4 [hp_X]/mL, RHODODENDRON TOMENTOSUM LEAFY TWIG 4 [hp_X]/mL, RANUNCULUS BULBOSUS 4 [hp_X]/mL, HORSE CHESTNUT 6 [hp_X]/mL, CUPRIC ACETATE 6 [hp_X]/mL, NADIDE 6 [hp_X]/mL, SODIUM DIETHYL OXALACETATE 6 [hp_X]/mL, NIACINAMIDE 6 [hp_X]/mL, PYRIDOXINE HYDROCHLORIDE 6 [hp_X]/mL, RIBOFLAVIN 6 [hp_X]/mL, THIAMINE HYDROCHLORIDE 6 [hp_X]/mL, ALPHA LIPOIC ACID 8 [hp_X]/mL, AMMONIUM CHLORIDE 8 [hp_X]/mL, SUS SCROFA CARTILAGE 8 [hp_X]/mL, SUS SCROFA INTERVERTEBRAL DISC 8 [hp_X]/mL, PICRIC ACID 8 [hp_X]/mL, SILICON DIOXIDE 8 [hp_X]/mL, SILVER 10 [hp_X]/mL, TRIBASIC CALCIUM PHOSPHATE 10 [hp_X]/mL, SUS SCROFA UMBILICAL CORD 10 [hp_X]/mL, SUS SCROFA ADRENAL GLAND 10 [hp_X]/mL, PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE 10 [hp_X]/mL, SUS SCROFA BONE MARROW 10 [hp_X]/mL, MERCURIC OXIDE 10 [hp_X]/mL, PANTOTHENIC ACID 10 [hp_X]/mL, SULFUR 28 [hp_X]/mL, ENTEROBACTER CLOACAE 30 [hp_C]/mL, SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS 30 [hp_C]/mL, PROTEUS MORGANII 30 [hp_C]/mL, PROTEUS VULGARIS 30 [hp_C]/mL

Vereinigte Staaten·Aktiv

Zulassungsinhaber: Deseret Biologicals, Inc.

Geprüft 2026-10-09 · openFDA NDC